Question 1

What is the catalog number for N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide?

Accepted Answer

The catalog number for N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide is sc-354760A.

Question 2

What sizes are available for N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide?

Accepted Answer

N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide is available in the following size(s): 5 g.

Question 3

Is N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide in stock?

Accepted Answer

N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 5

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

N- (4-Hydrazinocarbonyl-phenyl) -3-nitro-benzenesulfonamide

Product Specifications

Frequently Asked Questions

Explore Other Products

Ferritin, Heavy Chain (FTH) (Microglia Marker) (FTH/2081), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF568 conjugate, 0.1mg/mL

Cytokeratin 10/13 (DE-K13), 0.2mg/mL

CD8 (C8/468 + C8/144B), CF568 conjugate, 0.1mg/mL

PAX2 (Renal Cell & Ovarian Carcinoma Marker) (PAX2/1104), CF405S conjugate, 0.1mg/mL

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL